1. Effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation. Issue 4 (18th January 2016) Authors: Mujtaba, M. A.; Komocsar, W. J.; Nantz, E.; Samaniego, M. D.; Henson, S. L.; Hague, J. A.; Lobashevsky, A. L.; Higgins, N. G.; Czader, M.; Book, B. K.; Anderson, M. D.; Pescovitz, M. D.; Taber, T. E. Journal: American journal of transplantation Issue: Volume 16:Issue 4(2016:Apr.) Page Start: 1266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗